SEC Form 4 · accession 0001354488-17-000517
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Myron Kaplan
Director
Period of report
May 15, 2017
Accepted (ET)
May 17, 2017 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 15, 2017 | P | 30,000 | $0.494 | A | 50,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F2 | $2.24 | holding | — | — | — | — | Feb 21, 2027 | Common Stock | 40,000 | 40,000 | D |
| Restricted Stock UnitsF3 | — | holding | — | — | — | — | — | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy Common Stock)F4 | $4.28 | holding | — | — | — | — | Apr 28, 2026 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $0.472 to $0.500. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F2These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F3Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F4The options shall vest as follows: 1/3 on 4/28/2016, 1/3 on 4/28/2017, and 1/3 on 4/28/2018.